Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease

Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease

Introduction and Objectives: The optimal blood pressure (BP) range for patients with metabolic dysfunction-associated fatty liver disease (MAFLD) is currently unknown. This study aimed to explore the relationship between stratified BP levels and MAFLD progression. Patients and Methods: The data of a...

Full description

Bibliographic Details
Main Authors: Jing Liu, Haifeng Lv, Jie Wang, Qianru Zhu, Gongying Chen, Yanming Jiang, Ke Zhao, Li Shao, Junping Shi, Xiaoben Pan
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Annals of Hepatology
Subjects:
hypertension
Non-alcoholic fatty liver disease
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268122002344

Internet

http://www.sciencedirect.com/science/article/pii/S1665268122002344

Similar Items